Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis is FDA's first priority review voucher recipient for gaining approval of a tropical disease therapy
Novartis is FDA's first priority review voucher recipient for gaining approval of a tropical disease therapy
Novartis is FDA's first priority review voucher recipient for gaining approval of a tropical disease therapy
Submitted by
admin
on April 9, 2009 - 9:07am
Source:
InVivo
News Tags:
FDA
Novartis
malaria
review vouchers
Coartem
Headline:
Novartis is FDA's first priority review voucher recipient for gaining approval of a tropical disease therapy
Do Not Allow Advertisers to Use My Personal information
